MicroRNA-20b-5p effects on cartilage and subchondral bone angiogenesis in early-stage osteoarthritis rats

doi:10.12307/2022.852

Abstract

Abstract: BACKGROUND: Angiogenesis is an important pathological feature of early-stage knee osteoarthritis. Intra-articular injection of microRNA for the inhibition of angiogenesis may provide a new target for the treatment of early-stage knee osteoarthritis.
OBJECTIVE: To observe the effect of microRNA-20b-5p (miR-20b-5p) agomir on the angiogenesis of articular cartilage and subchondral bone in rats with early-stage knee osteoarthritis, and to explore the possible protective mechanism of miR-20b-5p.
METHODS: Twelve male Sprague-Dawley rats were enrolled, three of which were randomly selected as blank group, and the remaining nine rats were randomly divided into model group, miR-20b agomir group and miR-20b agomir NC group, with three rats in each group. One week after modeling, the blank group was not treated, while in the model, miR-20b agomir and miR-20b agomir NC groups, 0.2 mL of normal saline, miR-20b-5p agomir saline solution and miR-20b-5p agomir NC saline solution was injected into the rat bilateral knee joints, respectively. Four weeks later, the rats in each group were killed and the knee joints were taken for saffron O-fast green staining, immunohistochemical staining, and Osteoarthritis Research Society International scoring. Real-time fluorescence quantitative PCR and western blot assay were used to detect the expression of hypoxia inducible factor 1α and vascular endothelial growth factor at mRNA and protein levels in the cartilage and subchondral bone.
RESULTS AND CONCLUSION: The score of Osteoarthritis Research Society International in the miR-20b agomir group was significantly lower than that in the model group and miR-20b agomir NC group (P < 0.05), but there was no significant difference between model group and miR-20b agomir NC group (P > 0.05). The pathological sections of the knee joint showed that there was an increase in the loss of cartilage matrix and the expression of hypoxia inducible factor-1α and vascular endothelial growth factor proteins in the cartilage and subchondral bone in all intervention groups compared with the blank group. The degree of cartilage matrix loss and the expression of hypoxia inducible factor 1α and vascular endothelial growth factor proteins in the cartilage and subchondral bone in the miR-20b agomir group were lower than those in the model group and miR-20b agomir NC group. The mRNA and protein expression levels of hypoxia inducible factor 1α and vascular endothelial growth factor in the cartilage and subchondral bone in the miR-20b agomir group were significantly lower than those in the model group and miR-20b agomir NC group (P < 0.05). To conclude, overexpression of miR-20b-5p can protect early-stage osteoarthritis cartilage and subchondral bone by inhibiting angiogenesis mediated by the hypoxia-inducible factor 1α/vascular endothelial growth factor pathway.

Key words: early-stage knee osteoarthritis, microRNA-20b-5p, hypoxia-inducible factor 1α, vascular endothelial growth factor, angiogenesis

CLC Number:

Lu Qigui, Xie Pingjin, Luo Zhen, Li Feilong, Chen Qunqun, Chai Shengting. MicroRNA-20b-5p effects on cartilage and subchondral bone angiogenesis in early-stage osteoarthritis rats[J]. Chinese Journal of Tissue Engineering Research, 2022, 26(29): 4658-4665.

Figures/Tables 8

References

[1] VON KAEPPLER EP, WANG Q, RAGHU H, et al. Interleukin 4 promotes anti-inflammatory macrophages that clear cartilage debris and inhibits osteoclast development to protect against osteoarthritis. Clin Immunol. 2021;229:108784.
[2] IMHOF H, BREITENSEHER M, KAINBERGER F, et al. Degenerative joint disease: cartilage or vascular disease? Skeletal Radiol. 1997;26(7):398-403.
[3] FRÖHLICH LF. Micrornas at the Interface between Osteogenesis and Angiogenesis as Targets for Bone Regeneration. Cells. 2019;8(2):121.
[4] PUGH CW, RATCLIFFE PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med. 2003;9(6):677-684.
[5] LIU M, WANG D, LI N. MicroRNA-20b Downregulates HIF-1α and Inhibits the Proliferation and Invasion of Osteosarcoma Cells. Oncol Res. 2016;23(5):257-266.
[6] 谢平金,余翔,柴生颋,等.川芎嗪干预早期膝骨关节炎大鼠软骨Ⅱ型胶原纤维α1基因与血管内皮生长因子mRNA及miR20b的表达[J].中国组织工程研究,2018,22(12):1846-1851.
[7] 李飞龙,谢平金,柴生颋,等.川芎嗪对膝骨性关节炎大鼠软骨VEGF表达的影响[J].中国骨质疏松杂志,2018,24(7):904-909.
[8] 罗臻,李宏栩,卢启贵,等.红姜提取物保护早期膝骨关节炎模型大鼠的关节软骨[J].中国组织工程研究,2021,25(32):5155-5161.
[9] PRITZKER KP, GAY S, JIMENEZ SA, et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage. 2006; 14(1):13-29.
[10] LITWIC A, EDWARDS MH, DENNISON EM, et al. Epidemiology and burden of osteoarthritis. Br Med Bull. 2013;105:185-199.
[11] SAFIRI S, KOLAHI AA, SMITH E, et al. Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017. Ann Rheum Dis. 2020;79(6):819-828.
[12] WALSH DA. Angiogenesis and arthritis. Rheumatology (Oxford). 1999; 38(2):103-112.
[13] BURR DB, GALLANT MA. Bone remodelling in osteoarthritis. Nat Rev Rheumatol. 2012;8(11):665-673.
[14] PAN J, ZHOU X, LI W, et al. In situ measurement of transport between subchondral bone and articular cartilage. J Orthop Res. 2009;27(10): 1347-1352.
[15] ZANETTI M, BRUDER E, ROMERO J, et al. Bone marrow edema pattern in osteoarthritic knees: correlation between MR imaging and histologic findings. Radiology. 2000;215(3):835-840.
[16] HAWIGHORST H, LIBICHER M, KNOPP MV, et al. Evaluation of angiogenesis and perfusion of bone marrow lesions: role of semiquantitative and quantitative dynamic MRI. J Magn Reson Imaging. 1999;10(3):286-294.
[17] MAPP PI, WALSH DA. Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis. Nat Rev Rheumatol. 2012;8(7):390-398.
[18] SU W, LIU G, LIU X, et al. Angiogenesis stimulated by elevated PDGF-BB in subchondral bone contributes to osteoarthritis development. JCI Insight. 2020;5(8):e135446.
[19] MA L, ZHAO X, LIU Y, et al. Dihydroartemisinin attenuates osteoarthritis by inhibiting abnormal bone remodeling and angiogenesis in subchondral bone. Int J Mol Med. 2021;47(3):04855.
[20] HENROTIN Y, PESESSE L, LAMBERT C. Targeting the synovial angiogenesis as a novel treatment approach to osteoarthritis. Ther Adv Musculoskelet Dis. 2014;6(1):20-34.
[21] PATIL AS, SABLE RB, KOTHARI RM. Occurrence, biochemical profile of vascular endothelial growth factor (VEGF) isoforms and their functions in endochondral ossification. J Cell Physiol. 2012;227(4):1298-1308.
[22] HU K, OLSEN BR. Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair. J Clin Invest. 2016;126(2):509-526.
[23] HAMILTON JL, NAGAO M, LEVINE BR, et al. Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain. J Bone Miner Res. 2016;31(5):911-924.
[24] WALSH DA, BONNET CS, TURNER EL, et al. Angiogenesis in the synovium and at the osteochondral junction in osteoarthritis. Osteoarthritis Cartilage. 2007;15(7):743-751.
[25] BARRANCO C. Osteoarthritis: Animal data show VEGF blocker inhibits post-traumatic OA. Nat Rev Rheumatol. 2014;10(11):638.
[26] GIATROMANOLAKI A, SIVRIDIS E, MALTEZOS E, et al. Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis. Arthritis Res Ther. 2003;5(4):R193-201.
[27] KATOH M. Therapeutics targeting angiogenesis: genetics and epigenetics, extracellular miRNAs and signaling networks (Review). Int J Mol Med. 2013;32(4):763-767.
[28] PRASADAM I, BATRA J, PERRY S, et al. Systematic identification, characterization and target gene analysis of microRNAs involved in osteoarthritis subchondral bone pathogenesis. Calcif Tissue Int. 2016; 99(1):43-55.
[29] BORGONIO CUADRA VM, GONZALEZ-HUERTA NC, ROMERO-CORDOBA S, et al. Altered expression of circulating microRNA in plasma of patients with primary osteoarthritis and in silico analysis of their pathways. PLoS One. 2014;9(6):e97690.
[30] CHEN Y, ZHANG L, LI E, et al. Long-chain non-coding RNA HOTAIR promotes the progression of osteoarthritis via sponging miR-20b/PTEN axis. Life Sci. 2020;253:117685.
[30] QIN B, LIU J, LIU S, et al. MiR-20b targets AKT3 and modulates vascular endothelial growth factor-mediated changes in diabetic retinopathy. Acta Biochim Biophys Sin (Shanghai). 2016;48(8):732-740.
[32] 马玉峰,祁印泽,王庆甫,等.关节内注射药物建立骨性关节炎动物模型研究进展[J].中国骨伤,2015,28(1):90-95.
[33] JONES IA, TOGASHI R, WILSON ML, et al. Intra-articular treatment options for knee osteoarthritis. Nat Rev Rheumatol. 2019;15(2):77-90.
[34] WANG H, ZHANG H, SUN Q, et al. Intra-articular Delivery of Antago-miR-483-5p Inhibits Osteoarthritis by Modulating Matrilin 3 and Tissue Inhibitor of Metalloproteinase 2. Mol Ther. 2017;25(3):715-727.